Gano Kyle — SEC insider filings

SEC reporting owner CIK 1567160. 26 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2020-08-07 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Chief Executive Officer, Director26—34 legs · 253,959 sh · $31,664,36360

Insider filings — Gano Kyle

FiledFormIssuerReported transactionsSource
2026-11-034NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 614 @ $0 · Tax withholding (F): 332 @ $146.10 · Option exercise (M): 614 (derivative) @ $0EDGAR
2026-09-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 6,275 @ $0 · Tax withholding (F): 3,386 @ $156.22 · Grant/award (A): 1,842 @ $0 · Tax withholding (F): 994 @ $156.22EDGAR
2026-02-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 4,907 @ $0 · Tax withholding (F): 2,648 @ $123.10 · Option exercise (M): 2,241 @ $0 · Tax withholding (F): 1,210 @ $124.12 · Option exercise (M): 2,566 @ $0 · Tax withholding (F): 1,385 @ $124.12 · +7 moreEDGAR
2026-02-034NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,927 @ $0 · Tax withholding (F): 1,580 @ $136.06 · Option exercise (M): 2,927 (derivative) @ $0EDGAR
2026-01-204NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 34,588 @ $35.99 · Sale (S): 34,588 @ $132.70 · Option exercise (M): 1,812 @ $35.99 · Sale (S): 1,812 @ $132.71 · Option exercise (M): 34,588 (derivative) @ $0 · Option exercise (M): 1,812 (derivative) @ $0EDGAR
2025-11-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 613 @ $0 · Sale (S): 300 @ $141.97 · Option exercise (M): 613 (derivative) @ $0EDGAR
2025-02-144NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,566 @ $0 · Sale (S): 1,352 @ $116.84 · Option exercise (M): 2,241 @ $0 · Sale (S): 1,206 @ $116.86 · Grant/award (A): 104,736 (derivative) @ $0 · Grant/award (A): 19,628 (derivative) @ $0 · +2 moreEDGAR
2025-02-124NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.39 · Option exercise (M): 1,860 (derivative) @ $0EDGAR
2025-02-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,927 @ $0 · Sale (S): 1,541 @ $152.87 · Option exercise (M): 2,927 (derivative) @ $0EDGAR
2025-01-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 4,812 @ $32.99 · Sale (S): 4,812 @ $141.50 · Option exercise (M): 60,188 @ $32.99 · Sale (S): 60,188 @ $141.50 · Option exercise (M): 4,812 (derivative) @ $0 · Option exercise (M): 60,188 (derivative) @ $0EDGAR
2024-11-014NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,455 (derivative) @ $0 · Grant/award (A): 13,344 (derivative) @ $0EDGAR
2024-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,352 @ $132.89 · Grant/award (A): 45,058 (derivative) @ $0 · Grant/award (A): 8,966 (derivative) @ $0EDGAR
2024-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,600 @ $142.20 · Sale (S): 980 @ $134.20EDGAR
2024-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,541 @ $140.70EDGAR
2024-01-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 68,884 @ $19.59 · Sale (S): 68,884 @ $131.47 · Option exercise (M): 6,116 @ $19.59 · Sale (S): 6,116 @ $131.44 · Option exercise (M): 68,884 (derivative) @ $19.59 · Option exercise (M): 6,116 (derivative) @ $19.59EDGAR
2023-08-234NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,132 @ $107.41EDGAR
2023-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 63,789 (derivative) @ $0 · Grant/award (A): 10,264 (derivative) @ $0EDGAR
2023-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,600 @ $105.64 · Sale (S): 1,623 @ $102.29 · Sale (S): 12,801 @ $102.41 · Sale (S): 980 @ $103.99EDGAR
2023-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,541 @ $109.98EDGAR
2022-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 703 @ $80.68 · Sale (S): 1,974 @ $80.80 · Sale (S): 1,623 @ $80.78 · Sale (S): 1,600 @ $80.77 · Sale (S): 980 @ $79.67EDGAR
2022-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 79,720 (derivative) @ $0 · Grant/award (A): 11,706 (derivative) @ $0EDGAR
2022-01-074NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 28,266 @ $8.66 · Sale (S): 28,266 @ $85.50 · Option exercise (M): 28,266 (derivative) @ $8.66EDGAR
2021-03-294/ANEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 49,049 (derivative) @ $0EDGAR
2021-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 703 @ $113.77 · Sale (S): 1,974 @ $114.09 · Sale (S): 1,070 @ $116.89 · Sale (S): 1,000 @ $116.83 · Sale (S): 1,623 @ $116.83 · Grant/award (A): 44,632 (derivative) @ $0 · +1 moreEDGAR
2020-11-164NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $90.73EDGAR
2020-08-074NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $118.87EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1567160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs